Retina Vitreous Associates
Main Office
Plaza Medical Center
1200 Binz, Suite 400
Local: (713) 528-1122
Toll-Free: (800) 638-0114
Fax: (713) 528-7930
 
 
Salt Control
Both diabetic retinopathy and macular degeneration are responsive to dietary sodium restriction...
Click here for more information
 
 
Change Font Size
Make Text Bigger
Make Text Smaller
Return to default
 
 
 

 

 
About Retina-Vitreous Associates

Retina-Vitreous Associates is a subspecialty practice devoted to diseases and surgery of the retina and vitreous, i.e. diabetic retinopathy, aged macular degeneration, and retinal detachment.  Our Houston location is at 1200 Binz, in the museum district, immediately north of the Texas Medical Center.  We have several satellite locations, in space that is designated for our use by general-surgical ophthalmologists or therapeutic-trained optometrists.  These peripheral locations are fully equipped for diagnostic photography and, if necessary, for retinal laser coagulation.

Our satellite locations extend from Huntsville, 70 miles north of Houston, to Lake Jackson, which is 50 miles to the south.  We also service the Beaumont-Port Arthur-Orange triangle near the Louisiana state line.  And to the west, we provide care for retina-vitreous patients in Richmond, Sealy, and Bellville (click here to view all our locations).

When surgery becomes a necessary part of the therapeutic care we provide, the operative procedure is performed on an out-patient basis at Park Plaza, Methodist or St. Luke's Episcopal hospitals.  Following the operation, routine care is resumed at the satellite facility.

The Binz office is our primary location and it is at that location to which all telephone calls are directed.  Our staff of nine dedicated and highly trained employees provide prompt and efficient service.  They work with the physicians in a team of approach.  The field of retina-vitreous disease and surgery is dynamic and ever changing.  Physician and technician alike must be well informed of each and every emerging treatment option.  Our mission is to merge the advantages and disadvantages of all existing therapies and obtain the best ocular health for our patients.

Some of the new treatment modalities under evaluation by us are:

As the population ages, retinal problems become more commonplace.  We are ready and able to meet that need.